Page last updated: 2024-10-20

pyridoxine and Coronary Restenosis

pyridoxine has been researched along with Coronary Restenosis in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schnyder, G1
Roffi, M1
Pin, R1
Flammer, Y1
Lange, H1
Eberli, FR1
Meier, B1
Turi, ZG1
Hess, OM1

Trials

1 trial available for pyridoxine and Coronary Restenosis

ArticleYear
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    The New England journal of medicine, 2001, Nov-29, Volume: 345, Issue:22

    Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Corona

2001